CREYON Trademark

Trademark Overview


On Friday, July 23, 2021, a trademark application was filed for CREYON with the United States Patent and Trademark Office. The USPTO has given the CREYON trademark a serial number of 90846010. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, September 6, 2024. This trademark is owned by Creyon Bio, Inc.. The CREYON trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations and therapeutics for medical use, namely, oligonucleotides; drug delivery agents consisting of compounds that facilitate delivery of a wide range of Oligonucleotide-Based Medicines; pharmaceutical preparations of Oligonucleotide-Based Medicines for gene therapy, cell therapy, personalized medicine, and precision medicine; pharmaceutical preparations of Oligonucleotide-Based Medicines for use in the treatment of genetically based diseases and rare diseases; pharmaceutical preparations of oligonucleotide therapeutics for use in the treatment of genetically based diseases, multigenic diseases, rare diseases and ultra-rare diseases
creyon

General Information


Serial Number90846010
Word MarkCREYON
Filing DateFriday, July 23, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, September 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements


Goods and ServicesDiagnostic preparations and therapeutics for medical use, namely, oligonucleotides; drug delivery agents consisting of compounds that facilitate delivery of a wide range of Oligonucleotide-Based Medicines; pharmaceutical preparations of Oligonucleotide-Based Medicines for gene therapy, cell therapy, personalized medicine, and precision medicine; pharmaceutical preparations of Oligonucleotide-Based Medicines for use in the treatment of genetically based diseases and rare diseases; pharmaceutical preparations of oligonucleotide therapeutics for use in the treatment of genetically based diseases, multigenic diseases, rare diseases and ultra-rare diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 23, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCreyon Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameCreyon Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Tuesday, July 27, 2021NEW APPLICATION ENTERED
Thursday, September 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 18, 2022ASSIGNED TO EXAMINER
Thursday, May 12, 2022NON-FINAL ACTION WRITTEN
Thursday, May 12, 2022NON-FINAL ACTION E-MAILED
Thursday, May 12, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, September 15, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 15, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 20, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, September 15, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 20, 2023SOU EXTENSION 1 FILED
Wednesday, September 20, 2023SOU EXTENSION 1 GRANTED
Tuesday, March 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 6, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 6, 2024SOU EXTENSION 3 GRANTED
Friday, September 6, 2024SOU EXTENSION 3 FILED
Friday, September 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 11, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 11, 2024SOU EXTENSION 2 FILED
Monday, March 11, 2024SOU EXTENSION 2 GRANTED